Blood Disorder News and Research

RSS

Azerbaijan Thalassemia Center and BGI partner to improve thalassemia screening in Azerbaijan

On 6th September 2022, the Azerbaijan Thalassemia Center and BGI held a virtual signing ceremony to seal a Collaboration Agreement. The partnership aims to improve thalassemia screening in Azerbaijan through genetic technology.

16 Sep 2022

What are the risk factors related to COVID-19-related hospitalization and mortality?

In a new study, researchers assessed the risk factors associated with COVID-19-related hospitalization or mortality.

16 Aug 2022

Innovative Augmented Reality Joint Scanner unveiled at Westmead Children's Hospital to support young people with hemophilia

An Australian-designed, first-of-its-kind Augmented Reality technology has been unveiled today at The Children’s Hospital at Westmead (CHW). The technology will enable young people living with Hemophilia to view the potentially irreversible impact of disabling joint disease.

31 May 2022

Young adult men with sickle cell disease are unaware of SCD-associated fertility issues, study reveals

New research published today in Blood Advances indicates that many adolescent and young adult (AYA) men with sickle cell disease (SCD) are unaware of potential SCD-associated fertility issues, highlighting a need for comprehensive fertility education materials for this population.

21 Apr 2022

Big pharma is betting on bigger political ambitions from Sen. Tim Scott

Sen. Tim Scott, a rising star in the Republican Party with broad popularity in his home state of South Carolina, is getting showered with drug industry money before facing voters this fall.

28 Mar 2022

Gene therapy leads to durable transfusion independence in youngest patients with thalassemia

Over 90 percent of patients with transfusion-dependent thalassemia, an inherited blood disorder, no longer needed monthly blood transfusions years after receiving gene therapy, according to an international Phase 3 clinical trial that for the first time included children younger than 12 years of age.

22 Feb 2022

Drugs that increase fetal hemoglobin levels may help people with sickle cell disease

Sickle cell anemia is an inherited blood disorder where red blood cells become sickle/crescent shaped. It causes frequent infections, swelling in the hands and legs, pain, severe tiredness and delayed growth or puberty.

18 Feb 2022

Gene therapy may be a curative treatment option for patients with transfusion-dependent beta-thalassemia

A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia, according to a recent clinical trial published in The New England Journal of Medicine.

3 Feb 2022

SARS-CoV-2 virus may be shed for much longer periods by some infected patients, study shows

In a 38-year-old man who manifested mild symptoms of COVID-19 for 20 days, the novel coronavirus continued to be detected in his organism and to undergo mutations for 232 days.

27 Jan 2022

Research reveals key differences between childhood and adult chronic spontaneous urticaria

New research presented at EADV 30th Congress today unveils key insights on the characteristic differences in chronic spontaneous urticaria in children versus adults.

3 Oct 2021

Sepsis mortality risk linked to the degree of platelet reduction

Researchers have revealed that the degree of platelet reduction, rather than absolute platelet count, is linked to mortality risk in sepsis.

8 Sep 2021

Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment

New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more likely to respond to siltuximab, the only FDA approved treatment for the disease.

2 Sep 2021

UCSF launches new initiative to propel the development of living therapeutics

UC San Francisco is launching a new initiative to propel the development of living therapeutics - a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease - and bring them quickly to patients.

14 Jun 2021

Toward a transformative therapy for sickle cell patients

For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms.

9 Apr 2021

Scientists launch clinical trial of CRISPR gene correction therapy in patients with sickle cell disease

Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient's own blood-forming stem cells.

30 Mar 2021

Research could lead to a personalized approach for treating sickle cell disease

Sickle cell disease is the most prevalent inherited blood disorder in the world, affecting 70,000 to 100,000 Americans. However, it is considered an orphan disease, meaning it impacts less than 200,000 people nationally, and is therefore underrepresented in therapeutic research.

24 Mar 2021

Blood Disorder News and Research

Azerbaijan Thalassemia Center and BGI partner to improve thalassemia screening in Azerbaijan

What are the risk factors related to COVID-19-related hospitalization and mortality?

Innovative Augmented Reality Joint Scanner unveiled at Westmead Children's Hospital to support young people with hemophilia

Young adult men with sickle cell disease are unaware of SCD-associated fertility issues, study reveals

Big pharma is betting on bigger political ambitions from Sen. Tim Scott

Gene therapy leads to durable transfusion independence in youngest patients with thalassemia

Drugs that increase fetal hemoglobin levels may help people with sickle cell disease

Gene therapy may be a curative treatment option for patients with transfusion-dependent beta-thalassemia

SARS-CoV-2 virus may be shed for much longer periods by some infected patients, study shows

Research reveals key differences between childhood and adult chronic spontaneous urticaria

Sepsis mortality risk linked to the degree of platelet reduction

Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment

UCSF launches new initiative to propel the development of living therapeutics

Toward a transformative therapy for sickle cell patients

Scientists launch clinical trial of CRISPR gene correction therapy in patients with sickle cell disease

Research could lead to a personalized approach for treating sickle cell disease

Researchers develop new tool for tackling disseminated intravascular coagulation

Scientists uncover elusive mechanism behind the most severe cases of blood disorder

Scientists isolate anti-COVID-19 nanobodies produced by a llama

Study: Caplacizumab not cost effective for treating thrombotic thrombocytopenic purpura

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News